↓ Skip to main content

Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology

Overview of attention for article published in Frontiers in Cardiovascular Medicine, November 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology
Published in
Frontiers in Cardiovascular Medicine, November 2017
DOI 10.3389/fcvm.2017.00071
Pubmed ID
Authors

Dakota Gustafson, Shawn Veitch, Jason E. Fish

Abstract

Extracellular vesicles (EVs) represent an emerging mechanism of cell-cell communication in the cardiovascular system. Recent data suggest that EVs are produced and taken up by multiple cardiovascular cell types, influencing target cells through signaling or transfer of cargo (including proteins, lipids, messenger RNA, and non-coding RNA). The concentration and contents of circulating EVs are altered in several diseases and represent explicit signatures of cellular activation, making them of particular interest as circulating biomarkers. EVs also actively contribute to the progression of various cardiovascular diseases, including diabetes-related vascular disease. Understanding the relationships between circulating EVs, diabetes, and cardiovascular disease is of importance as diabetic patients are at elevated risk for developing several debilitating cardiovascular pathologies, including diabetic cardiomyopathy (DCM), a disease that remains an enigma at the molecular level. Enhancing and exploiting our understanding of EV biology could facilitate the development of effective non-invasive diagnostics, prognostics, and therapeutics. This review will focus on EV biology in diabetic cardiovascular diseases, including atherosclerosis and DCM. We will review EV biogenesis and functional properties, as well as provide insight into their emerging role in cell-cell communication. Finally, we will address the utility of EVs as clinical biomarkers and outline their impact as a biomedical tool in the development of therapeutics.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 175 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 36 21%
Student > Master 27 15%
Student > Ph. D. Student 24 14%
Student > Doctoral Student 10 6%
Researcher 7 4%
Other 15 9%
Unknown 56 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 48 27%
Medicine and Dentistry 14 8%
Agricultural and Biological Sciences 10 6%
Immunology and Microbiology 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 28 16%
Unknown 64 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2019.
All research outputs
#3,154,069
of 23,007,887 outputs
Outputs from Frontiers in Cardiovascular Medicine
#383
of 6,928 outputs
Outputs of similar age
#62,186
of 331,173 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#2
of 25 outputs
Altmetric has tracked 23,007,887 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,928 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,173 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.